- Published at
- by manilatimes.net
positive
positive
News for Grifols, S.A. (GIFOF)
- Published at
- by gurufocus.com
positivepositiveMason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General Meeting | GRFS Stock News
Mason Capital Management supports Grifols' recommended director slate at the upcoming shareholder meeting. Mason holds approximately 3% of Grifols' class A- Published at
- by seekingalpha.com
neutralneutralGrifols, S.A. (GRFS) Q1 2025 Earnings Conference Call Transcript
Grifols, S.A. (NASDAQ:GRFS) Q1 2025 Earnings Conference Call May 12, 2025 12:30 PM ETCompany ParticipantsDanny Segarra - VP, IR and SustainabilityNacho Abia...- Published at
- by seekingalpha.com
neutralneutralGrifols, S.A. 2025 Q1 - Results - Earnings Call Presentation (NASDAQ:GRFS)
The following slide deck was published by Grifols, S.A.- Published at
- by gurufocus.com
mixedmixedRigel Reports First Quarter 2025 Financial Results and Provides Business Update
PR NewswireSOUTH SAN FRANCISCO, Calif., May 6, 2025 First quarter 2025 total revenue of approximately $53.3 million, which includes net product sales of $4- Published at
- by finance.yahoo.com
positivepositiveHere’s White Falcon’s Views on Grifols, S.A. (GRFS)
White Falcon Capital Management, an investment fund manager, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund’s performance for the recent quarter was below expectations, as the gains from gold and silver royalty holdings were unable to cover the losses in some of the larger positions. On […]- Published at
- by insidermonkey.com
neutralneutralHere’s White Falcon’s Views on Grifols, S.A. (GRFS)
White Falcon Capital Management, an investment fund manager, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.- Published at
- by gurufocus.com
neutralneutralRigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
PR NewswireSOUTH SAN FRANCISCO, Calif., March 4, 2025 Fourth quarter 2024 total revenue of approximately $57.6 million, which includes TAVALISSE® net prod- Published at
- by insidermonkey.com
positivepositiveIs Grifols, S.A. (GRFS) the Best Low Price Pharma Stock to Invest In Right Now?
We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Grifols, S.A.- Published at
- by seekingalpha.com
neutralneutralGrifols, S.A. 2024 Q3 - Results - Earnings Call Presentation (NASDAQ:GRFS)
The following slide deck was published by Grifols, S.A.- Published at
- by investing.com
positivepositiveMason Capital Management Requests Immediate Disclosure of Important Information Regarding Conflicted Grifols Director Tomas Daga By Investing.com
Mason Capital Management Requests Immediate Disclosure of Important Information Regarding Conflicted Grifols Director Tomas Daga- Published at
- by benzinga.com
mixedmixedDell, HP, CrowdStrike, 3D Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - CrowdStrike Holdings (NASDAQ:CRWD), Autodesk (NASDAQ:ADSK)
U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Wednesday. Shares of Dell Technologies Inc. DELL fell sharply in t...- Published at
- by investing.com
mixedmixedMason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors By Investing.com
Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors- Published at
- by globenewswire.com
mixedmixedGlobal Plasma Protein Therapeutics Market to Touch ~USD 40 Billion Mark by 2030 | DelveInsight
The plasma protein therapeutics market is experiencing notable growth, driven by the essential role these therapies play in treating various conditions...- Published at
- by globenewswire.com
neutralneutralInfectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology
Infectious Disease Diagnostics Market size was valued at USD 22.94 billion in 2023 to USD 43.09 billion by 2031...- Published at
- by globenewswire.com
mixedmixedBlood Screening Market Growth at USD 6.33 Billion by 2031 | SkyQuest Technology
Discover the booming blood screening market from 2024 to 2031, as innovative technologies and rising health awareness drive demand across diverse product...- Published at
- by globenewswire.com
mixedmixedGigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat
The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1...- Published at
- by benzinga.com
mixedmixedSnowflake, Hawaiian Electric Industries And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Snowflake (NYSE:SNOW)
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Tuesday. Shares of Snowflake Inc. SNOW fell in today's pre-mar...- Published at
- by medium.com
mixedmixedUS Blood Transfusion Diagnostics Market: Ensuring Safe and Efficient Blood Transfusions
As per Fortune Business Insights’ report, the us blood transfusion diagnostics market share sector attained a worth of USD 1.91 billion in 2021. Forecasts indicate a promising path, foreseeing a…- Published at
- by medium.com
mixedmixedImmune Thrombocytopenia Market: Novel Therapies Targeting Platelet Disorders
As per Fortune Business Insights’ report, the immune thrombocytopenia Market share sector attained a worth of USD 2.99 Billion in 2018. Forecasts indicate a promising path, foreseeing a Compound…